We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+8.14%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3B
AUM Growth
-$140M
Cap. Flow
-$317M
Cap. Flow %
-10.57%
Top 10 Hldgs %
28.72%
Holding
6,693
New
497
Increased
2,742
Reduced
2,422
Closed
658

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$73.5M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$65.4M
3
MSFT icon
Microsoft
MSFT
+$34M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$12.5M
5
CMCSA icon
Comcast
CMCSA
+$11.4M

Top Sells

Rank Stock Value
1
TSM icon
TSMC
TSM
+$335M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$140M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$82.7M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$40.4M
5
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$22.8M

Sector Composition

Rank Sector Weight
1 Technology 18.86%
2 Financials 7.81%
3 Consumer Discretionary 7.79%
4 Industrials 7.37%
5 Healthcare 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PWOD
4676
DELISTED
Penns Woods Bancorp
PWOD
$6.63K ﹤0.01%
265
-7
-3% -$170
LUXE
4677
LuxExperience B.V.
LUXE
$1.08B
$6.62K ﹤0.01%
1,655
-13
-0.8% -$62
CDIO icon
4678
Cardio Diagnostics
CDIO
$5.45M
$6.6K ﹤0.01%
185
+142
+330% +$8.01K
MRAM icon
4679
Everspin Technologies
MRAM
$392M
$6.6K ﹤0.01%
717
-1,922
-73% -$14.5K
HSTO
4680
DELISTED
Histogen Inc. Common Stock
HSTO
$6.59K ﹤0.01%
9,270
+1,554
+20% +$1.39K
ATXI
4681
DELISTED
Avenue Therapeutics, Inc. Common Stock
ATXI
$6.59K ﹤0.01%
75
-32
-30% -$2.64K
NXTC icon
4682
NextCure
NXTC
$30.5M
$6.58K ﹤0.01%
305
-870
-74% -$17.1K
MARK
4683
DELISTED
Remark Holdings, Inc.
MARK
$6.58K ﹤0.01%
6,715
-6,595
-50% -$7.7K
DJP icon
4684
iPath Bloomberg Commodity Index Total Return ETN due 12 June 2036
DJP
$815M
$6.57K ﹤0.01%
215
-16
-7% -$494
GCBC icon
4685
Greene County Bancorp
GCBC
$584M
$6.56K ﹤0.01%
220
-1,568
-88% -$37.8K
QIPT
4686
DELISTED
Quipt Home Medical
QIPT
$6.55K ﹤0.01%
+1,227
New +$7.24K
AFCG
4687
AFC Gamma
AFCG
$63.2M
$6.55K ﹤0.01%
768
-744
-49% -$6.03K
OPGN
4688
DELISTED
OpGen, Inc
OPGN
$6.54K ﹤0.01%
802
+762
+1,905% +$6.22K
EDBL
4689
Edible Garden
EDBL
$1.13M
– –
0
– –
XTNT icon
4690
Xtant Medical Holdings
XTNT
$48.5M
$6.52K ﹤0.01%
7,013
+1,734
+33% +$1.16K
ADEX.U
4691
DELISTED
Adit EdTech Acquisition Corp Units
ADEX.U
$6.52K ﹤0.01%
613
– –
BIOC
4692
DELISTED
Biocept, Inc.
BIOC
$6.52K ﹤0.01%
5,389
+5,110
+1,832% +$28.9K
THRX
4693
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$6.51K ﹤0.01%
698
-720
-51% -$7.09K
TRVN
4694
DELISTED
Trevena, Inc.
TRVN
$6.51K ﹤0.01%
295
-122
-29% -$2.99K
BWMX icon
4695
Betterware México
BWMX
$611M
$6.5K ﹤0.01%
+503
New +$6.08K
OGEN icon
4696
Oragenics
OGEN
$2.47M
$6.5K ﹤0.01%
66
+1
+2% +$93
DERM icon
4697
Journey Medical
DERM
$178M
$6.49K ﹤0.01%
4,082
-1,337
-25% -$2.15K
VOR icon
4698
Vor Biopharma
VOR
$1.29B
$6.49K ﹤0.01%
+105
New +$9.59K
LABP
4699
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
$6.49K ﹤0.01%
1,542
-584
-27% -$1.85K
PETV
4700
DELISTED
PetVivo Holdings, Inc. Common Stock
PETV
$6.48K ﹤0.01%
3,291
-306
-9% -$722
186 187
188
189 190

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2023 Portfolio in Review

As of Q2 2023, Tower Research Capital (TRC) held 6,693 positions worth $3B, down 4.5% from $3.14B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) withdrew a net $317M in Q2 2023, closing 658 positions and reducing 2,422 holdings. Its most notable exit was iShares Russell 2000 Growth ETF, an estimated $22.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares MSCI USA Min Vol Factor ETF worth $5.5M.

  • Tower Research Capital (TRC)'s largest Q2 2023 buy was iShares MSCI USA Min Vol Factor ETF: 74,022 shares worth $5.5M.
  • Tower Research Capital (TRC) added most to Apple in Q2 2023, an estimated $73.5M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2023 reduction was TSMC, cutting an estimated $335M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q2 2023, selling an estimated $22.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $3B portfolio in Q2 2023.
  • Tower Research Capital (TRC) opened 497 new positions and closed 658 in Q2 2023.
  • Tower Research Capital (TRC)'s portfolio value fell 4.5% quarter-over-quarter to $3B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2023, filed 14 Aug 2023.